MedTrace Logo

Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers

NCT06891586 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-03-27

No results posted yet for this study

Summary

In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.

Conditions

  • Newborn Morbidity
  • Newborn Complication

Interventions

DIAGNOSTIC_TEST

echocardiographic evaluation and blood phoenixin-14 level

For participants who provide consent, blood samples will be collected at 6 hours postpartum. Additionally, infants included in the study will undergo an echocardiographic evaluation by a pediatric cardiologist between postnatal days 3 and 5.

Sponsors & Collaborators

  • Konya City Hospital

    lead OTHER

Principal Investigators

  • MELEK BUYUKEREN · Konya City Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
5 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-10-01
Completion
2026-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06891586 on ClinicalTrials.gov